(NYSE: PFE) Pfizer's forecast annual revenue growth rate of -5.24% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 3.44%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.17%.
Pfizer's revenue in 2023 is $77,944,000,000.On average, 6 Wall Street analysts forecast PFE's revenue for 2023 to be $375,272,134,557,867, with the lowest PFE revenue forecast at $368,121,306,570,039, and the highest PFE revenue forecast at $383,208,535,714,305. On average, 6 Wall Street analysts forecast PFE's revenue for 2024 to be $373,557,733,288,477, with the lowest PFE revenue forecast at $338,795,306,147,806, and the highest PFE revenue forecast at $395,781,765,857,000.
In 2025, PFE is forecast to generate $374,998,316,810,641 in revenue, with the lowest revenue forecast at $334,814,712,688,331 and the highest revenue forecast at $408,406,131,455,520.